FindTrial
Sign In

Study on Mechanism and Prevention Strategy of Liver Transplantation Ischemia-reperfusion Injury

Study on Mechanism and Prevention Strategy of Liver Transplantation Ischemia-reperfusion Injury

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200064912
Enrollment
Unknown
Registered
2022-10-21
Start date
2021-10-20
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End stage liver disease

Interventions

None listed

Sponsors

Department of Anesthesiology, the Third Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 82 Years

Inclusion criteria

Inclusion criteria: 2022.4.1-2023.03.31 Patients undergoing non-living liver transplantation in our hospital.

Exclusion criteria

Exclusion criteria: Donor >= 75-year-old, severe fatty liver donor liver transplantation and living donor liver transplantation.

Design outcomes

Primary

MeasureTime frame
Inflammatory factor level;—

Countries

China

Contacts

Public ContactGe Mian

Department of Anesthesiology, the Third Affiliated Hospital of Sun Yat-sen University

gemiansums@163.com+86 13570303090

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026